Sakura Finetek USA, Inc., announced on January 5 that it had acquired 100% of the stock of GeneMed Biotechnologies Inc., of South San Francisco, California, along with its “tissue-based advanced staining business for cancer detection, diagnosis, and monitoring.” GeneMed’s liquid-based molecular products were not part of the acquisition and will be put into an independent business. […]
January 19, 2016 Intelligence: Late Breaking Lab News
- By Robert Michel
- > From the Volume XXIII, No. 1 - January 19, 2016 Issue
